Dichloroacetic acid

From Wikipedia, the free encyclopedia
(Redirected from Dicholoroacetate)
Jump to navigation Jump to search

<templatestyles src="Chembox/styles.css"/>

Template:Chembox AllOtherNamesTemplate:Chembox headerbarTemplate:Chembox IndexlistTemplate:Chembox JmolTemplate:Chembox ChEMBLTemplate:Chembox ECHATemplate:Chembox E numberTemplate:Chembox IUPHAR ligandTemplate:Chembox UNIITemplate:Chembox CompToxTemplate:Chembox headerbarTemplate:Chembox SolubilityInWaterTemplate:Chembox headerbarTemplate:Chembox headerbarTemplate:Chembox GHS (set)Template:Chembox SDSTemplate:Chembox headerbarTemplate:Chembox Datapage checkTemplate:Chembox Footer
Dichloroacetic acid
Template:Chembox image sbs cell
Template:Longitem Template:Unbulleted list
Template:Longitem 1098596
ChEBI Template:Unbulleted list
ChemSpider Template:Unbulleted list
DrugBank Template:Unbulleted list
EC Number Template:Unbulleted list
Template:Longitem 2477
KEGG Template:Unbulleted list
MeSH Dichloroacetate
Template:Longitem Template:Unbulleted list
RTECS number Template:Unbulleted list
UN number 1764
Script error: No such module "collapsible list".
Script error: No such module "collapsible list".
Template:Longitem Template:Chembox Elements/molecular formula
Molar mass Template:Chem molar mass
Appearance Colorless liquid
Density 1.5634 g/cm3 (20 °C)
Melting point Template:Chembox CalcTemperatures
Boiling point Template:Chembox CalcTemperatures
Solubility miscible with ethanol, diethyl ether[1]
Acidity (pKa) 1.35[1]
Template:Longitem −58.2·10−6 cm3/mol
Template:Longitem −496.3 kJ·mol−1[1]
NFPA 704 (fire diamond) Template:NFPA 704 diamond
Template:Longitem Chloroacetic acid
Trichloroacetic acid
Template:Longitem Acetic acid
Difluoroacetic acid
Dibromoacetic acid

Template:Chembox Footer/trackingScript error: No such module "TemplatePar".Template:Short description

Dichloroacetic acid (DCA), sometimes called bichloroacetic acid (BCA), is the organic compound with formula Template:Chem2. It is an analogue of acetic acid, in which 2 of the 3 hydrogen atoms of the methyl group have been replaced by chlorine atoms. Like the other chloroacetic acids, it has various practical applications. The salts and esters of dichloroacetic acid are called dichloroacetates.

Reactions

The chemistry of dichloroacetic acid is typical for halogenated organic acids. It is an alkylating agent. It forms esters.

It is a member of the chloroacetic acids family. As such it is more acidic than acetic acid. It fully dissociates into dichloroacetate when dissolved in water, consistent with it pKa of 1.35,[1] pure dichloroacetic acid is classed as a strong organic acid; it is very corrosive and extremely destructive to tissues of the mucous membranes and upper respiratory tract via inhalation.[2]

Natural occurrence

DCA has been shown to occur in nature in at least one seaweed, Asparagopsis taxiformis [3] and also in the mushroom Russula nigricans.[4] It is a trace product of the chlorination of drinking water and is produced by the metabolism of various chlorine-containing drugs or chemicals.[5] DCA is typically prepared by the reduction of trichloroacetic acid (TCA).[6] DCA is prepared from chloral hydrate also by the reaction with calcium carbonate and sodium cyanide in water followed by acidifying with hydrochloric acid.[7]

As a laboratory reagent, both DCA and TCA[8] are used as precipitants to prompt macromolecules such as proteins to precipitate out of solution.[9]

Therapeutic uses

Salts of DCA have been studied as potential drugs because they inhibit the enzyme pyruvate dehydrogenase kinase.[10] Although preliminary studies found that DCA can slow the growth of certain tumors in animal studies and in vitro studies, as of 2012 insufficient evidence supported the use of DCA for cancer treatment.[11]

Lactic acidosis

A randomized controlled trial in children with congenital lactic acidosis found that while DCA was well tolerated, it was ineffective in improving clinical outcomes.[12] A separate trial of DCA in children with MELAS (a syndrome of inadequate mitochondrial function, leading to lactic acidosis) was halted early, as all 15 of the children receiving DCA experienced significant nerve toxicity without any evidence of benefit from the medication.[13] A randomized controlled trial of DCA in adults with lactic acidosis found that while DCA lowered blood lactate levels, it had no clinical benefit and did not improve hemodynamics or survival.[14]

Thus, while early case reports and pre-clinical data suggested that DCA might be effective for lactic acidosis, subsequent controlled trials have found no clinical benefit of DCA in this setting. In addition, clinical trial subjects were incapable of continuing on DCA as a study medication owing to progressive toxicities.

Cancer

In 2007 reports emerged in the press and via the Internet that Evangelos Michelakis and coworkers at the University of Alberta had reported that sodium dichloroacetate reduced tumors in rats and killed cancer cells in vitro.[15] Because the drug cannot be patented, financing the broad and expensive testing required to obtain FDA approval is problematic.[16] The US Food and Drug Administration enforces the law that prohibits the sale of substances with the suggestion that they are cancer treatments unless they have been approved by the FDA.[17]

The American Cancer Society in 2012 stated that "available evidence does not support the use of DCA for cancer treatment at this time."[11] Physicians warned of potential problems if people attempt to try DCA outside a controlled clinical trial.[18] One problem with attempting this is obtaining the chemical. One fraudster was sentenced to 33 months in prison for selling a white powder containing starch, but no DCA, to people with cancer.[19]

The only monitored in vivo dosage of five human patients with glioblastoma with DCA was not designed to test its efficacy against their cancer. This study was rather to see whether it could be given at a specific dosage safely without causing side effects (e.g. neuropathy). All five patients were receiving other treatments during the study.[20][21] Observations in vitro and of tumours extracted from those five patients suggest that DCA might act against cancer cells by depolarising abnormal mitochondria found in glioblastoma cancer cells – allowing the mitochondria to induce apoptosis (cell death) of the malignant cells.[20] In vitro work with DCA on neuroblastomas (which have fewer recognised mitochondrial abnormalities) showed activity against malignant, undifferentiated cells.[22] A 2016 case report discussed and reviewed the application of DCA in central nervous system malignancies.[23] A 2018 study found that DCA could trigger a metabolic switch from glycolysis (the Warburg effect) to mitochondrial OXPHOS and increase reactive oxygen stress affecting tumor cells. These effects were not observed in non-tumor cells.[24]

Neuropathy

Neuropathy has been a problem in some clinical trials with DCA causing them to be effectively halted,[13] but a 2008 BJC review found that it has not occurred in other DCA trials.[25] The mechanism of DCA induced neuropathy is not well understood.[26] On the one hand in vitro work with nerves has suggested a mechanism for the neuropathic effect of DCA; with DCA showing a dose and exposure dependent demyelination of nerves (stripping of the nerve 'sheath'), which demyelination was partially reversible over time, following washout of DCA.[27] On the other hand, the 2008 review in BJC [25] states "This neurotoxicity resembled the pattern of length-dependent, axonal, sensorimotor polyneuropathy without demyelination." with regard to the 2006 study by Kaufman et al.[13]

Heart failure

DCA has been investigated as a treatment for post-ischemic recovery.[28] There is also evidence that DCA improves metabolism by NADH production stimulation, but may lead to a depletion of NADH in normoxia.[29]

See also

References

<templatestyles src="Reflist/styles.css" />

  1. ↑ a b c d Template:RubberBible92nd
  2. ↑ Script error: No such module "citation/CS1".
  3. ↑ [1] Script error: No such module "webarchive".
  4. ↑ Script error: No such module "Citation/CS1".
  5. ↑ Script error: No such module "Citation/CS1".
  6. ↑ Script error: No such module "Citation/CS1".
  7. ↑ Script error: No such module "Citation/CS1".
  8. ↑ Script error: No such module "citation/CS1".
  9. ↑ Script error: No such module "Citation/CS1".
  10. ↑ Script error: No such module "Citation/CS1".
  11. ↑ a b Script error: No such module "citation/CS1".
  12. ↑ Script error: No such module "Citation/CS1".
  13. ↑ a b c Script error: No such module "Citation/CS1".
  14. ↑ Script error: No such module "Citation/CS1".
  15. ↑ Script error: No such module "Citation/CS1". The original article did not have quotation marks around the word "safe".
  16. ↑ Script error: No such module "Citation/CS1".
  17. ↑ Script error: No such module "Citation/CS1".
  18. ↑ Script error: No such module "citation/CS1".
  19. ↑ Script error: No such module "citation/CS1".
  20. ↑ a b Script error: No such module "Citation/CS1".
  21. ↑ Script error: No such module "citation/CS1".
  22. ↑ Script error: No such module "Citation/CS1".
  23. ↑ Script error: No such module "Citation/CS1".
  24. ↑ Script error: No such module "Citation/CS1".
  25. ↑ a b Script error: No such module "Citation/CS1".
  26. ↑ Script error: No such module "citation/CS1".
  27. ↑ Script error: No such module "Citation/CS1".
  28. ↑ Script error: No such module "Citation/CS1".
  29. ↑ Script error: No such module "Citation/CS1".

Script error: No such module "Check for unknown parameters".

External links

Template:Unproven and disproven cancer treatments

Retrieved from "http://debianws.lexgopc.com/wiki143/index.php?title=Dichloroacetic_acid&oldid=2110765"